Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Geneos Therapeutics logo

Geneos Therapeutics

Recent Finacing

Series A III

Recent Raise

$5M

Geneos Therapeutics is a clinical-stage biotherapeutics firm using its GT-EPIC platform to design, manufacture, and deliver DNA plasmid-based personalized neoantigen cancer vaccines, including GNOS-PV02 in HCC combination trials.

Founded 2016
Pennsylvania, United States
1-10
Private
geneostx.com

Highlights

Focus Areas

Biotechnology
Health Care
Oncology
Pharmaceutical
Therapeutics

Recent Investors

INOVIO Pharmaceuticals logo
Korea Investment Partners logo
Saints Capital logo
Global Bio Fund logo
Sante Ventures logo
Flerie Invest logo
3B Future Health Fund logo

Financials

$44.5M

Total Raised

4

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Geneos Therapeutics.